USFDA flags 7 likely violations in check of NATCO Pharma’s Hyderabad unit | Industry News


Natco Pharma, Natco

Upon conclusion of the inspection, the company received seven observations in Form 483 | Photo: X@pharma_natco

NATCO Pharma Limited on Saturday said it has received seven observations from the US health regulator following an inspection of its manufacturing facility in Kothur, Hyderabad.

The US Food and Drug Administration (USFDA) conducted an inspection of the company’s plant during November 12-20, NATCO Pharma said in a regulatory filing.

Upon conclusion of the inspection, the company received seven observations in Form 483, it added.

In USFDA parlance, a Form-483 is issued to a firm’s management at the conclusion of an inspection when investigators observe conditions that, in their judgment, may constitute violations of the laws.

“The company believes that the observations are procedural in nature and is confident of addressing these observations comprehensively within stipulated timelines,” NATCO Pharma said.

 

First Published: Nov 21 2026 | 2:38 PM IST

Latest Posts

Don't Miss

US FDA flags blindness risk from GLP-1 drugs: What patients should know | Health News

 The US Food and Drug Administration (FDA) has flagged a

Grand Lord Ganesha Idol Installed with Traditional Rituals in Hasoud

Gaura Chaura Ganesh Utsav Committee organises ceremonial installation; devotees pray

Chhattisgarh Police Crack Blind Murder Case: Five Arrested, Two Juveniles Detained in Contract Killing Linked to Cannabis Trade Rivalry

Balodabazar-Bhatapara, Chhattisgarh | The Balodabazar-Bhatapara Police have achieved a major

Pope denounces ‘suffering and humiliation’ of African enslaved people during Peru visit

A pope who has already apologised for slavery In his